About Anteris Technologies
Anteris Technologies is a publicly listed company based in Brisbane (Australia) founded in 2011. Technologies for heart valve development are provided. The company has 136 employees. Its chief executive, as recorded, is Wayne Paterson. Anteris Technologies offers products and services including DurAVR® THV. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is ANTERIS TECHNOLOGIES CORPORATION.
Company details
Anteris Technologies was founded in 2011 in Brisbane, Australia, focusing on medical device innovations in the cardiovascular sector. Patented ADAPT technology is utilized to create the 3D single-piece DurAVR aortic heart valve. Additional products include the DurAVR leaflet repair system, transcatheter heart valve, and surgical heart valve, supporting advancements in heart valve treatments through research and development operations.
- Headquarters Brisbane, Australia
- Employees 136
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website anteristech.com/home.html
- Social LinkedIn X Facebook YouTube
- Legal Name Anteris Technologies Global Corp.
- Annual Revenue$1.91 M (USD)-29.23as on Dec 31, 2025
- Net Profit-$94.14 M (USD)-23.4as on Dec 31, 2025
- EBITDA-$92.23 M (USD)-19.99as on Dec 31, 2025
- Latest Funding Round$11.5M (USD), Post-IPO
Oct 2025
- InvestorsHHS
& 3 more
- Employee Count136
Products & Services of Anteris Technologies
Anteris Technologies offers a comprehensive portfolio of products and services, including DurAVR® THV.
Transcatheter heart valve designed to mimic natural aortic function.
Apps and channels of Anteris Technologies
its YouTube channel Anteris Technologies has 305 subscribers and 24 videos.
Videos from Anteris Technologies
The most watched videos on Anteris Technologies's YouTube channel, Anteris Technologies (305 subscribers). Click a video to play it here.
More on Anteris Technologies.
Funding Insights of Anteris Technologies
- Total Rounds 15
- Last Round Post-IPO — $11.5M
- First Round $1.59M
(Jun 2009)
- Investors Count 4
Latest 10 of 15 funding rounds of Anteris Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $11.5M | Post-IPO | – | – | – |
| Apr 2024 | $15.16M | Post-IPO | – | – | – |
| Mar 2022 | $20M | Post-IPO | – | – | |
| Oct 2021 | $3.75M | Post-IPO | – | – | – |
| Aug 2021 | $9M | Post-IPO | – | – | – |
| May 2021 | $1.78M | Post-IPO | – | – | – |
| Dec 2020 | $1.9M | Post-IPO | – | – | |
| Nov 2018 | $20.2M | Post-IPO | – | – | |
| Sep 2018 | Post-IPO | – | – | – | |
| May 2018 | $6M | Post-IPO | – | – | – |
4 investors in total: 4 institutional.
Investors in Anteris Technologies
Anteris Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Mercer and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Consulting and investment services are provided to organizations across sectors. | 1945 | mercer.com | New York, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| starbrightholding.tcc.mode |
Investor details for Anteris Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Anteris Technologies
17 people are tracked at Anteris Technologies (10 in leadership, 7 in team); the tracked headcount is 136.
| Name | Role | Group |
|---|---|---|
Wayne Paterson | Managing Director & CEO | Leadership |
Tyler Aman | Director, Organizational Development & Effectiveness | Leadership |
Paul Hinkley | Director Of Operations | Leadership |
Brian Dumke | Vice President Operations | Leadership |
Debbie Ormsby | Vice President Global Investor Relations And Corporate Development | Leadership |
Matthew Mcdonnell | Chief Financial Officer | Leadership |
Michael Oswell | Vice President Of Technical Operations & Development | Leadership |
Christopher Meduri | Chief Medical Officer | Leadership |
Julian Chick | COO | Leadership |
Whitney Giga | Vice President Human Resources | Leadership |
Mark Jamieson | Planning, Reporting & Commercial Manager (part-time) | Team |
Hailey Schuck | Human Resources Manager | Team |
Jeff Hadler | Controller | Team |
Julie Lamb | Revenue Accouting Officer | Team |
Sarah Melvin | Controller - Tax And Accounting | Team |
Andrew Bertelsmeier | Senior Group Technology Manager | Team |
Erica Almgren Steffenson | Sr Talent Acquisition Manager | Team |
Complete people profiles for Anteris Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Anteris Technologies
Anteris Technologies is a publicly listed company on the NASDAQ with ticker symbol AVR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Dec 2024
- Listed onNASDAQ: AVR
- Listed entityAnteris Technologies Global Corp.
- Exchange sectorHealth technology
- ISINUS03675P1021
- Share price$6.45 (-3.01% on the day) · 2026-10-13
- Market capitalisation$628.6M
- EPS (diluted, trailing year)$-1.94
- Volume (last session)764,297
Financials of Anteris Technologies
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.9M | -$94.1M | -$92.2M |
| 2024 | $2.7M | -$76.3M | -$76.9M |
| 2023 | $2.7M | -$46.0M | -$46.2M |
| 2022 | $3.2M | -$30.6M | -$32.0M |
Detailed financial statements for Anteris Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Anteris Technologies
4 dated milestones of Anteris Technologies across 16 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $1.6M.
- Founded Anteris Technologies is founded.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $11.5M.
Web traffic of Anteris Technologies
The website of Anteris Technologies (anteristech.com) receives about 5K visits a month.
- Monthly visits5K
▼ 21% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Anteris Technologies
Complete news archive for Anteris Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anteris Technologies
Anteris Technologies was founded in 2011.
Anteris Technologies is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Wayne Paterson is the CEO of Anteris Technologies, as recorded in our data.
Anteris Technologies has 136 employees.
Annual revenue of Anteris Technologies is $1.91M as on Dec 31, 2025.
Anteris Technologies was founded in 2011 in Brisbane, Australia, focusing on medical device innovations in the cardiovascular sector. Patented ADAPT technology is utilized to create the 3D single-piece DurAVR aortic heart valve. Additional products include the DurAVR leaflet repair system, transcatheter heart valve, and surgical heart valve, supporting advancements in heart valve treatments through research and development operations.
Anteris Technologies offers DurAVR® THV.
Yes, Anteris Technologies is publicly traded on NASDAQ under the ticker symbol AVR.
Anteris Technologies has 4 investors. Key investors include HHS, Mercer, Perceptive Advisors, and Star Bright Holding.
Anteris Technologies operates through Anteris Technologies Corporation.